Alpha Crest Capital Management LLC Intercept Pharmaceuticals, Inc. Transaction History

Alpha Crest Capital Management LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 12, 2021	SELL	$15.46 - $24.5 $223,922 - $354,858	-14,484 Closed	0 $0
Q1 2021 May 13, 2021	SELL	$19.33 - $37.75 $83,872 - $163,797	-4,339 Reduced 23.05%	14,484 $334,000
Q4 2020 Feb 12, 2021	BUY	$24.48 - $42.47 $260,271 - $451,541	10,632 Added 129.8%	18,823 $465,000
Q3 2020 Nov 12, 2020	BUY	$39.09 - $53.44 $83,535 - $114,201	2,137 Added 35.3%	8,191 $340,000
Q2 2020 Aug 12, 2020	BUY	$46.7 - $92.04 $28,954 - $57,064	620 Added 11.41%	6,054 $290,000
Q1 2020 May 13, 2020	BUY	$48.35 - $118.68 $19,001 - $46,641	393 Added 7.8%	5,434 $342,000
Q4 2019 Feb 12, 2020	SELL	$57.36 - $124.1 $270,739 - $585,752	-4,720 Reduced 48.36%	5,041 $625,000
Q3 2019 Nov 12, 2019	BUY	$58.69 - $80.46 $572,873 - $785,370	9,761 New	9,761 $648,000

1.04M

30K

5.9K

Ticker ICPT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 41,127,400
Description
Intercept Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of therapeutics to treat progressive non-viral liver diseases in the United States, Europe, and Canada. The company markets Ocaliva, a farnesoid X receptor agonist used for the treatment of primary biliary cholangitis in combination wit...

Get notified when there are updates to the investment portfolio of Alpha Crest Capital Management LLC, based on Form 13F filings with the SEC.

Stay updated on Alpha Crest Capital Management LLC with notifications on news.